Explore the vast range of titles available.

When the goat pasture is plagued with a foul stench, the Princess in Black and her friends must take on a stinky beast.

“Xinyi” ( Magnolia biondii Pampan., Magnolia denudata Desr., and Magnolia sprengeri Pampan.) is a traditional Chinese medicine listed in the Pharmacopoeia of the People’s Republic of China. “Xinyi” has anti-inflammatory, anti-allergic, antioxidant, and antibacterial effects, and has significant curative effects in the treatment of acute and chronic rhinitis, allergic rhinitis, and other rhinitis symptoms. However, comparative quality assessments of these three species are scarce. This study investigated the variations in the volatile oil content and composition in the flower buds of M. biondii , M. denudata , and M. sprengeri using the gas chromatography–mass spectrometry (GC–MS) and the microscopic analysis at different growth stages. This study indicated the following findings. (1) The volatile oil levels varied among the species, with M. biondii , M. denudata , and M. sprengeri peaking, respectively. In addition, the cell density was positively correlated with the oil deposition. (2) The content of 1,8-Cineole varied significantly, where M. biondii exhibited the high levels at 14.50% at stage 4 and 16.40% at stage 5; M. denudata peaked at 17.87% at stage 5; and M. sprengeri was 1.07% at stage 3. Moreover, M. biondii and M. denudata from Hubei exceeded the Pharmacopoeia’s 1% standard, whereas M. sprengeri did not. These findings underscore the need to improve the herb production standards and provide valuable data for assessing the therapeutic potential of these “Xinyi” species.

This study rigorously investigates the bioactive properties and characteristics of extracts derived from the flowers and bark of four distinct Magnolia species: Magnolia champaca, Magnolia denudata, Magnolia grandiflora and Magnolia officinalis. The primary objective is to evaluate the potential application of these extracts in cosmetics and other relevant industries. We used ethanol to extract compounds from these plants and conducted various tests, including spectrophotometry, HPLC, GC-MS, and microbiological analyses. The extracts, particularly rich in polyphenols (55.18 mg GAE/g), displayed significant antioxidant capabilities, with IC 50 values ranging between 9.99 mg/mL and 23.23 mg/mL. We quantified different compounds: phenolic acids (6.259 to 27.883 mg/g dry weight), aglycone flavonoids (61.224 to 135.788 mg/g dw), glycosidic flavonoids (17.265 to 57.961 mg/g dw), and lignans (150.071 to 374.902 mg/g dw). We identified 76 volatile compounds, predominantly oxygenated monoterpenes and sesquiterpene hydrocarbons, which contribute to the antibacterial effectiveness of the extracts. These extracts showed greater inhibitory potential against Gram-negative bacteria than Gram-positive bacteria. The diverse chemical compounds and their demonstrated activities suggest these extracts could be valuable in the cosmetics industry, pharmaceutical industry, or other industries.

Background Magnolia officinalis ( M. officinalis) thrives in temperate, elevated regions, and its desiccated bark comprises medicinal monolignol. Both abiotic and biotic factors can influence the pharmacodynamic compounds of M. officinalis , which display a variety of capabilities. It was the goal of this study to find the main bioclimatic factors that impact the amount of helpful compounds in M. officinalis and to show how these bioclimatic factors influence the metabolic pathways of magnolol and honokiol through actions on transcripts and molecules. We assessed the amounts of medicinal compounds in M. officinalis from Baoxing (BX), Nanjiang (NJ), Xuanhan (XH), and Beichuan (BC) in Sichuan Province. After that, the bioclimatic factors were gathered and put together that affected the growth and used the transcriptome and metabolome to label the M. officinalis data. The associated metabolic pathways were analyzed based on significant alterations in bioclimatic factors. Results Temperature and precipitation influence the accumulation of bioactive compounds in M. officinalis , as well as the metabolism of monolignol, amino acids, flavonoids, α-linolenic acid, and arachidonic acids. Moreover, temperature was negatively related to the mounts of phenylalanine ammonia-lyase ( PAL ), 4-coumarate-CoA ligase ( 4CL ), and cinnamoyl-CoA reductase ( CCR ) in the monolignol biosynthetic pathway, as well as to the amounts of cinnamyl alcohol and 4-coumaryl alcohol that were made. Conclusions Moderate temperatures and appropriate precipitation enhanced the metabolism of monolignols in M. officinalis , ascribed to elevated levels of effective enzyme that correlated with the temperature and precipitation modulation of PAL , 4CL , and CCR activity. Furthermore, this study discovered that cinnamonyl alcohol and 4-coumaryl alcohol were critical precursors for the production of magnolol and honokiol, indicating potential strategies for improving M. officinalis ' pharmacodynamic characteristics.

Magnolia flower buds are a source of herbal medicines with various active compounds. In this study, differences in the distribution and abundance of major essential oils, phenolic acids, and primary metabolites between white flower buds of Magnolia heptapeta and violet flower buds of Magnolia denudata var. purpurascens were characterised. A multivariate analysis revealed clear separation between the white and violet flower buds with respect to primary and secondary metabolites closely related to metabolic systems. White flower buds contained large amounts of monoterpene hydrocarbons (MH), phenolic acids, aromatic amino acids, and monosaccharides, related to the production of isoprenes, as MH precursors, and the activity of MH synthase. However, concentrations of β-myrcene, a major MH compound, were higher in violet flower buds than in white flower buds, possibly due to higher threonine levels and low acidic conditions induced by comparatively low levels of some organic acids. Moreover, levels of stress-related metabolites, such as oxygenated monoterpenes, proline, and glutamic acid, were higher in violet flower buds than in white flower buds. Our results support the feasibility of metabolic profiling for the identification of phytochemical differences and improve our understanding of the correlated biological pathways for primary and secondary metabolites.

In this study, two phenol compounds, magnolol and honokiol, were extracted from Magnolia officinalis and identified by LC-MS, 1H- and 13C-NMR. The magnolol and honokiol were shown to be effective against seven pathogenic fungi, including Alternaria alternata (Fr.) Keissl, Penicillium expansum (Link) Thom, Alternaria dauci f.sp. solani, Fusarium moniliforme J. Sheld, Fusarium oxysporum Schltdl., Valsa mali Miyabe & G. Yamada, and Rhizoctonia solani J.G. Kühn, with growth inhibition of more than 57%. We also investigated the mechanisms underlying the potential antifungal activity of magnolol and honokiol. The results showed that they inhibited the growth of A. alternata in a dose-dependent manner. Moreover, magnolol and honokiol treatment resulted in distorted mycelia and increased the cell membrane permeability of A. alternata, as determined by conductivity measurements. These results suggest that magnolol and honokiol are potential antifungal agents for application against plant fungal diseases.

Magnolol (4-allyl-2-(5-allyl-2-hydroxyphenyl)phenol),the main bioactive constituent of the medicinal plant Magnolia officinalis, and its main metabolite tetrahydromagnolol were recently found to activate cannabinoid (CB) receptors. We now investigated the structure-activity relationships of (tetrahydro)magnolol analogs with variations of the alkyl chains and the phenolic groups and could considerably improve potency. Among the most potent compounds were the dual CB1/CB2 full agonist 2-(2-methoxy-5-propyl-phenyl)-4-hexylphenol(61a, Ki CB1:0.00957 mu M; Ki CB2:0.0238 mu M), and the CB2-selective partial agonist 2-(2-hydroxy-5-propylphenyl)-4-pentylphenol(60, Ki CB1:0.362 mu M; Ki CB2:0.0371 mu M), which showed high selectivity versus GPR18 and GPR55. Compound 61b, an isomer of 61a, was the most potent GPR55 antagonist with an IC50 value of 3.25 mu M but was non-selective. The relatively simple structures, which possess no stereocenters, are easily accessible in a four- to five-step synthetic procedure from common starting materials. The central reaction step is the well-elaborated Suzuki-Miyaura cross-coupling reaction, which is suitable for a combinatorial chemistry approach. The scaffold is versatile and may be fine-tuned to obtain a broad range of receptor affinities, selectivities and efficacies.

Magnolia sirindhorniae Noot. & Chalermglin is an endangered species with high ornamental and commercial value that needs to be urgently protected and judiciously commercialized. In this study, a protocol for efficient regeneration of this species is standardized. The lateral buds of the M. sirindhorniae plant were used as an explant. Half-strength Murashige and Skoog (MS) medium supplemented with 2.0 mg/L 6-benzyladenine (BA), 0.1 mg/L α-naphthaleneacetic acid (NAA), and 2.0 mg/L gibberellic acid (GA 3 ) was found to be the optimal medium for shoot induction. The maximum shoot multiplication rate (310%) was obtained on Douglas-fir cotyledon revised medium (DCR) fortified with 0.2 mg/L BA, 0.01 mg/L NAA, and additives. The half-strength DCR medium supplemented with 0.5 mg/L NAA and 0.5 mg/L indole-3-butyric acid (IBA) supported the maximum rate (85.0%) of in vitro root induction. After a simple acclimatization process, the survival rate of plantlets in a substrate mixture of sterile perlite and peat soil (1:3; v/v ) was 90.2%. DNA markers were used for assessment of genetic uniformity, confirming the genetic uniformity and stability of regenerated plants of M. sirindhorniae . Thus, the described protocol can safely be applied for large scale propagation of this imperative plant.

Magnolia trees ( Magnolia sp.) are a popular choice for consumers when choosing flowering woody plants for landscapes. Magnolia species grow in a wide variety of both temperate and tropical locations. Southern magnolia ( Magnolia grandiflora ) is one of the more popular magnolias due to its pleasing aesthetics: large showy flowers in a range of colors and evergreen foliage. However, magnolias can be affected by algal leaf spot. Algal leaf spot is caused by Cephaleuros virescens , which is a widespread plant parasitic green alga. There has been little research on how to treat algal leaf spot on magnolia plants. This study focuses on identifying effective biological- and chemical-based fungicides for the management of algal leaf spot disease of magnolia plants. Two experiments were conducted in a randomized complete block design with six replications per treatment and a total of 12 treatments, including a nontreated control. The first experiment (Expt. 1) was conducted in a shade house (56% shade) at McMinnville, TN, using southern magnolia plants. The second experiment (Expt. 2) was conducted at a commercial nursery in McMinnvillle, TN, in a field plot planted with ‘Jane’ magnolia ( Magnolia liliiflora ‘Nigra’ × Magnolia stellata ‘Rosea’). The algal leaf spot disease severity, disease progression, plant marketability and growth parameters were evaluated. In both experiments, all treatments reduced algal leaf spot disease severity and disease progress in comparison with the nontreated control. In Expt. 1, copper octanoate, copper oxychloride, chlorothalonil water-dispersible granules, chlorothalonil suspension concentrate, didecyl dimethyl ammonium chloride, azoxystrobin + benzovindiflupyr, hydrogen peroxide + peroxyacetic acid, and mono- and di-potassium salts of phosphorus acid + hydrogen peroxide reduced the disease severity and disease progress the most and were not statistically different from one another. In Expt. 2, azoxystrobin + benzovindiflupyr, didecyl dimethyl ammonium chloride, and copper oxychloride significantly reduced disease severity and disease progress (area under disease progress curve). Treatments had no deleterious effect on plant growth parameters such as height and width, and no phytotoxicity of applied treatments or defoliation was observed. Treated magnolia plants had better plant marketability compared with the nontreated control plants. The findings of this study will help growers to achieve better management of algal leaf spot disease on magnolia trees.

We tested Magnolia grandiflora L. (Magnoliales: Magnoliaceae) seed essential oil and its pure compounds for their repellency and toxicity against workers of hybrid imported fire ants. Series of dosages were tested starting from 156 µg/g to the dose where the treatment failed. Workers removed significantly less sand from the vials with M. grandiflora seed essential oil and 1-octanol treated sand at serial dosages of 156–4.9 µg/g than the solvent control whereas the amount removed at 2.4–0.6 µg/g was similar to the solvent control. In 1-decanol treatments, workers removed significantly less sand at serial dosages of 156–0.15 µg/g than the solvent control whereas the removal of sand at the dose of 0.08 µg/g was similar to the solvent control. In DEET (N, N-diethyl-meta-toluamide) treatments, workers removed significantly less sand at serial dosages of 156–78 µg/g than the solvent control whereas the quantity of removed sand at 39 µg/g was similar to the solvent control. Based on the mean amount of sand removed, M. grandiflora essential oil, 1-decanol, and 1-octanol showed significantly higher repellency than DEET. 1-Decanol and 1-octanol, present in seed essential oil showed toxicity against fire ant workers. 1-Decanol with LC50 of 140.6 µg/g was the most toxic natural compound followed by 1-octanol (LC50 = 486.8 µg/g). Bifenthrin with LC50 value of 0.018 µg/g showed much higher toxicity than these natural compounds. High repellency and toxicity of 1-decanol makes it a natural compound of interest for further studies under field conditions.